Currently holds positions in Astex Pharmaceuticals Inc and Xenon Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Chief Medical Officer | Astex Pharmaceuticals Inc | July 21, 2009 - |
Independent Director | Xenon Pharmaceuticals Inc | Oct. 1, 2003 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2022-05-25 | 2022-05-24 |
DURECT Corp
(DRRX)
|
B Purchase |
5,000
+9.1%
0.391,950 USD |
5,000 +9.1% | 0.39 | 1,950 USD | |
2022-05-25 | 2022-05-24 |
DURECT Corp
(DRRX)
|
B Purchase |
10,000
+22.2%
0.393,889 USD |
10,000 +22.2% | 0.39 | 3,889 USD | |
2022-05-25 | 2022-05-24 |
DURECT Corp
(DRRX)
|
B Purchase |
5,000
+12.5%
0.381,895 USD |
5,000 +12.5% | 0.38 | 1,895 USD | |
2022-05-25 | 2022-05-24 |
DURECT Corp
(DRRX)
|
B Purchase |
5,000
+14.3%
0.391,942 USD |
5,000 +14.3% | 0.39 | 1,942 USD | |
2022-05-25 | 2022-05-24 |
DURECT Corp
(DRRX)
|
B Purchase |
5,000
+16.7%
0.391,963 USD |
5,000 +16.7% | 0.39 | 1,963 USD | |
2022-05-18 | 2022-05-17 |
DURECT Corp
(DRRX)
|
B Purchase |
1,800
+6.4%
0.42758 USD |
1,800 +6.4% | 0.42 | 758 USD | |
2022-05-18 | 2022-05-17 |
DURECT Corp
(DRRX)
|
B Purchase |
8,900
+46.1%
0.423,749 USD |
8,900 +46.1% | 0.42 | 3,749 USD | |
2022-05-18 | 2022-05-17 |
DURECT Corp
(DRRX)
|
B Purchase |
9,300
+93.0%
0.423,899 USD |
9,300 +93.0% | 0.42 | 3,899 USD | |
2022-05-18 | 2022-05-16 |
DURECT Corp
(DRRX)
|
B Purchase |
10,000
+inf%
0.383,767 USD |
10,000 +inf% | 0.38 | 3,767 USD | |
2019-09-17 | 2019-09-13 |
Xenon Pharmaceuticals Inc
(XENE)
|
S Sale |
23
-0.0%
9.31214 USD |
23 -0.0% | 9.31 | 214 USD |